middle.news
How Will Island Pharmaceuticals Leverage Its New Galidesivir Covid-19 Patent?
10:01am on Friday 5th of December, 2025 AEDT
•
Healthcare
Read Story
How Will Island Pharmaceuticals Leverage Its New Galidesivir Covid-19 Patent?
10:01am on Friday 5th of December, 2025 AEDT
Key Points
US Patent Number 12,472,197 granted for Galidesivir’s Covid-19 treatment use
Patent protection extended through July 2042 in the United States
Strengthens Island’s broad-spectrum antiviral IP portfolio
Supports regulatory progress for Galidesivir’s Marburg virus indication
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE